These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
282 related articles for article (PubMed ID: 21266977)
1. ERK5 signalling in prostate cancer promotes an invasive phenotype. Ramsay AK; McCracken SR; Soofi M; Fleming J; Yu AX; Ahmad I; Morland R; Machesky L; Nixon C; Edwards DR; Nuttall RK; Seywright M; Marquez R; Keller E; Leung HY Br J Cancer; 2011 Feb; 104(4):664-72. PubMed ID: 21266977 [TBL] [Abstract][Full Text] [Related]
2. MEK5 overexpression is associated with metastatic prostate cancer, and stimulates proliferation, MMP-9 expression and invasion. Mehta PB; Jenkins BL; McCarthy L; Thilak L; Robson CN; Neal DE; Leung HY Oncogene; 2003 Mar; 22(9):1381-9. PubMed ID: 12618764 [TBL] [Abstract][Full Text] [Related]
3. Proteomic analysis of tumor necrosis factor-alpha resistant human breast cancer cells reveals a MEK5/Erk5-mediated epithelial-mesenchymal transition phenotype. Zhou C; Nitschke AM; Xiong W; Zhang Q; Tang Y; Bloch M; Elliott S; Zhu Y; Bazzone L; Yu D; Weldon CB; Schiff R; McLachlan JA; Beckman BS; Wiese TE; Nephew KP; Shan B; Burow ME; Wang G Breast Cancer Res; 2008; 10(6):R105. PubMed ID: 19087274 [TBL] [Abstract][Full Text] [Related]
4. Upregulation of MEK5 by Stat3 promotes breast cancer cell invasion and metastasis. Liu F; Zhang H; Song H Oncol Rep; 2017 Jan; 37(1):83-90. PubMed ID: 27878304 [TBL] [Abstract][Full Text] [Related]
6. SATB2 suppresses the progression of colorectal cancer cells via inactivation of MEK5/ERK5 signaling. Mansour MA; Hyodo T; Ito S; Kurita K; Kokuryo T; Uehara K; Nagino M; Takahashi M; Hamaguchi M; Senga T FEBS J; 2015 Apr; 282(8):1394-405. PubMed ID: 25662172 [TBL] [Abstract][Full Text] [Related]
7. ERK5 and its role in tumour development. Lochhead PA; Gilley R; Cook SJ Biochem Soc Trans; 2012 Feb; 40(1):251-6. PubMed ID: 22260700 [TBL] [Abstract][Full Text] [Related]
8. The transcription factor FOXF1 promotes prostate cancer by stimulating the mitogen-activated protein kinase ERK5. Fulford L; Milewski D; Ustiyan V; Ravishankar N; Cai Y; Le T; Masineni S; Kasper S; Aronow B; Kalinichenko VV; Kalin TV Sci Signal; 2016 May; 9(427):ra48. PubMed ID: 27165781 [TBL] [Abstract][Full Text] [Related]
9. Resistance to MAPK Inhibitors in Melanoma Involves Activation of the IGF1R-MEK5-Erk5 Pathway. Benito-Jardón L; Díaz-Martínez M; Arellano-Sánchez N; Vaquero-Morales P; Esparís-Ogando A; Teixidó J Cancer Res; 2019 May; 79(9):2244-2256. PubMed ID: 30833419 [TBL] [Abstract][Full Text] [Related]
10. MEK5/ERK5 signaling suppresses estrogen receptor expression and promotes hormone-independent tumorigenesis. Antoon JW; Martin EC; Lai R; Salvo VA; Tang Y; Nitzchke AM; Elliott S; Nam SY; Xiong W; Rhodes LV; Collins-Burow B; David O; Wang G; Shan B; Beckman BS; Nephew KP; Burow ME PLoS One; 2013; 8(8):e69291. PubMed ID: 23950888 [TBL] [Abstract][Full Text] [Related]
11. Mitogenic growth signalling, DNA replication licensing, and survival are linked in prostate cancer. Dudderidge TJ; McCracken SR; Loddo M; Fanshawe TR; Kelly JD; Neal DE; Leung HY; Williams GH; Stoeber K Br J Cancer; 2007 May; 96(9):1384-93. PubMed ID: 17406359 [TBL] [Abstract][Full Text] [Related]
12. Requirement of the MEK5-ERK5 pathway for neural differentiation in Xenopus embryonic development. Nishimoto S; Kusakabe M; Nishida E EMBO Rep; 2005 Nov; 6(11):1064-9. PubMed ID: 16179948 [TBL] [Abstract][Full Text] [Related]
13. The MEK5-ERK5 Kinase Axis Controls Lipid Metabolism in Small-Cell Lung Cancer. Cristea S; Coles GL; Hornburg D; Gershkovitz M; Arand J; Cao S; Sen T; Williamson SC; Kim JW; Drainas AP; He A; Cam LL; Byers LA; Snyder MP; Contrepois K; Sage J Cancer Res; 2020 Mar; 80(6):1293-1303. PubMed ID: 31969375 [TBL] [Abstract][Full Text] [Related]
14. BIX02189 inhibits TGF-β1-induced lung cancer cell metastasis by directly targeting TGF-β type I receptor. Park SJ; Choi YS; Lee S; Lee YJ; Hong S; Han S; Kim BC Cancer Lett; 2016 Oct; 381(2):314-22. PubMed ID: 27543359 [TBL] [Abstract][Full Text] [Related]
15. Aberrant MEK5/ERK5 signalling contributes to human colon cancer progression via NF-κB activation. Simões AE; Pereira DM; Gomes SE; Brito H; Carvalho T; French A; Castro RE; Steer CJ; Thibodeau SN; Rodrigues CM; Borralho PM Cell Death Dis; 2015 Apr; 6(4):e1718. PubMed ID: 25855966 [TBL] [Abstract][Full Text] [Related]
16. Activation of either ERK1/2 or ERK5 MAP kinase pathways can lead to disruption of the actin cytoskeleton. Barros JC; Marshall CJ J Cell Sci; 2005 Apr; 118(Pt 8):1663-71. PubMed ID: 15797923 [TBL] [Abstract][Full Text] [Related]